Metabolic
1 drug is in development for Amyloidosis.
- Companies
- 1
- Clinical trials
- 11
BioSniper AIPage evidence connected
Prepared research question
Which programs lead the Amyloidosis pipeline—and what evidence could change the picture?
Run cited research
Traceable citations · Unknowns marked
Drug Pipeline by Phase
Phase 3(1)
| Drug | Company |
|---|---|
| nexiguran ziclumeran | Intellia Therapeutics, Inc. (NTLA) |
About this indication
Amyloidosis context
Metabolic·MeSH: Amyloidosis (D000686)
Also known as: Amyloidoses
Frequently asked questions
How many drugs are in development for Amyloidosis?
BioSniper tracks 1 drug in development for Amyloidosis across 1 company.
How many clinical trials target Amyloidosis?
There are 11 clinical trials targeting Amyloidosis tracked by BioSniper.